Neuroinflammation in Alzheimer's disease

Area of Science:

• Neuroimmunology
• Alzheimer's Disease Pathogenesis

Background:

• Alzheimer's disease (AD) pathogenesis extends beyond neurons, involving significant brain immune interactions.
• Misfolded proteins activate microglia and astroglia, initiating innate immune responses and inflammation.
• Genetic risk factors for sporadic AD often relate to glial clearance and inflammatory regulation.

Purpose of the Study:

• To explore the role of neuroinflammation in Alzheimer's disease.
• To investigate how glial cells contribute to AD pathology.
• To identify potential therapeutic targets within immune pathways.

Main Methods:

• Review of current evidence on neuroimmunology in AD.
• Analysis of genome-wide association studies (GWAS) for AD risk genes.
• Consideration of external factors influencing brain immunity.

Main Results:

• Innate immune responses in the brain are implicated in AD progression.
• Glial cells (microglia, astroglia) play a key role in clearing misfolded proteins and mediating inflammation.
• Genetic factors influencing glial function are linked to AD risk.
• Systemic factors like inflammation and obesity exacerbate AD pathology.

Conclusions:

• Alzheimer's disease involves complex neuroimmune interactions.
• Targeting glial immune responses and modifiable risk factors presents therapeutic and preventive opportunities for AD.